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Abstract. Purpose: A novel approach using nano technology enhanced
radiation modalities is investigated. The proposed methodology uses antibodies
labeled with organically inert metals with a high atomic number. Irradiation using
photons with energies in the kilo–electron volt (keV) range show an increase in
dose due to a combination of an increase in photo–electric interactions and a
pronounced generation of Auger and/or Coster–Kro¨nig (A–CK) electrons.
Methods: The dependency of the dose deposition on various factors is
investigated using Monte Carlo simulation models. The factors investigated
include: agent concentration, spectral dependency looking at mono–energetic
sources as well as classical bremsstrahlung sources. The optimization of the
energy spectrum is performed in terms of physical dose enhancement as well as
the dose deposited by Auger and/or Coster–Kro¨nig electrons and their biological
effectiveness.
Results: A quasi–linear dependency on concentration and an exponential
decrease within the target medium is observed. The maximal dose enhancement
is dependent on the position of the target in the beam. Apart from irradiation
with low photon energies (10 – 20 keV) there is no added benefit from the increase
in generation of Auger electrons. Interestingly, a regular 110kVp bremsstrahlung
spectrum shows a comparable enhancement in comparison with the optimized
mono–energetic sources.
Conclusions: In conclusion we find that the use of nano–particle enhanced
shows promise to be implemented quite easily in regular clinic on a physical level
due to the advantageous properties in classical beams.
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1. Introduction
Recently, methodologies using monoclonal antibodies that target specific tumor cells
have been used to bring active compounds in the vicinity of these cells. One
approach uses radioactive compounds of α– or β–emitters[1, 2, 3]. Alternatively,
chemotherapeutic compounds have been attached to this delivery mechanism. The
use of such approaches is interesting but limited due to the fact that the therapeutic
compound is already active at time of delivery and during secretion by the body.
More in particular with radioactive compounds an important whole body dose (red
marrow dose) as well as renal toxicity are limiting factors for the efficacy of the
treatment[4, 5, 6, 7].
It is the goal of this paper to investigate a delivery method that could potentially
have most of the benefits associated with the previously listed therapeutic modalities
a´nd has almost none of the disadvantages. Which means:
(i) Differentiation between malignant and healthy cells.
(ii) Enhanced effectiveness.
(iii) Image guidance possibilities.
(iv) Activation methodology (i.e. Only active were it needs to be active).
(v) Large therapeutic window.
Dose enhancement due to the presence of gold nano–particles has been proposed
already both by means of an injectable contrast agent as by the use of mono–clonal
antibodies or other targetted delivery methods.. However, the enhancement relied
on an increased interaction due to the increased probability of the photo–electric
interaction being dependent on the atomic number at the proposed energies and the
specific contribution of Auger electrons was not investigated[8, 9, 10, 11, 12]. All
sources used in these studies were spectral sources and/or brachytherapy sources.
Moreover, proposals to use more sophisticated photon sources have been put forward,
in the hope to maximize the efficiency of the conversion of the beam energy to
deposited energy as well as generate a high amount of Auger electrons[13].
In the dose deposition model proposed here a significant part of the energy is
deposited by Auger electrons. There is reason to believe that Auger electrons deposit
their energy more efficiently than those emanating from Compton or photo–electric
effect processes. The exact mechanism behind this apparant dose enhancement effect is
still unclear. A possible cause is the fact that Auger have a very low energy and deposit
all of the energy within a range comparable to a few cell diameters. Furthermore, there
is a possible change in the stopping power energy dependency at very low energies
(<10keV), where the Bethe formalism breaks down. Alternatively, it could be that on
average more than a single Auger electron is being produced, increasing the probability
of clustered double strand breaks.
A number of authors have investigated the biological effects indirectly and support
the notion that Auger electrons indeed have high LET characteristics[14, 15, 16].
To our knowledge. a systematic study of the impact of different spectral sources
on the enhancement and the possible biological enhancement has not been published.
2. Methods and Materials
To perform the planning simulation we used MCNPX (Monte Carlo N-Particle
eXtended)[17] version 2.7a running on a 738 node cluster at the University of Leuven.
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The department of experimental radiotherapy at Leuven is part of the beta–test group
for MCNPX. The following physical parameters were used during these simulations.
Photon energy cutoff: 1keV.
electron energy cutoff: 1keV.
EM interaction library: ENDF/B-VI Release 8 Photoatomic Data 02/07/03
For the spectral dose deposition from Auger electrons version 2.7b was used. As
the version is only available to use as a single processor binary it was not possible
to run this on the cluster. Therefore if we did not need information on the Auger
electrons seperately we chose to use the earlier version.
2.1. Geometry
The simulation geometry consisted of a tank filled with water containing three 1mm
thick cylindrical slabs holding tissue as defined by ORNL report TM8381. One slab
was positioned at the surface of the tank representing a skin surface. A second
slab was positioned at 5cm distance from the tank surface down stream from the
source. In this slab varying concentrations of gold were added in a homogeneous
distribution. Additionally, geometrically identical slabs containing tissue, were
positioned downstream adjacent to the structure containing the gold particles. The
source in this geometry was a plane source (not divergent). The divergence can be
introduced depending of the position of the source in a clinical situation by applying
a inverse square rule.
Water
H2O
Source
ORNL
Tissue
ORNL
Tissue + Au trace
Figure 1: The geometry used in this simulation. The geometry has three volumes where dose can be
measured: A skin section at the edge of the area, a target volume, and an organ at risk volume adjacent
to the target volume. Alternatively the third volume can be used as a layer of target volume to study the
effect of upstream nano–particles.
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2.2. Source
The radiation source is modeled after mono–energetic radiation sources obtained by
Bragg–Gray diffraction of regular X–ray sources. Although these sources are called
mono–energetic, they do exhibit some spectral spread which was modeled as a normal
distribution with a σ= 1.5keV.
2.3. Simulations
2.3.1. Energies To investigate the energy dependence of the therapeutic window,
we performed the same simulation with quasi–mono–energetic beams of energies
ranging from 10 to 200 keV, with special consideration to the Kα–energy of gold (i.e.
80.67keV). Additionally, a broad spectrum beam was investigated. The spectrum was
taken to be identical to that coming from an Acuity simulator’s X–ray tube (Varian
Inc.) running at 110kVp.
2.3.2. Concentrations The medium used in the activated environment was considered
to be tissue as defined in the (Oak Ridge National Labs (ORNL) Report TM-8381).
Gold (Z=79) in natural isotope abundance was added with all other components
diminished to yield a normalized weight. The structures were embedded in water.
The concentrations of gold in one of the structures varied between 0 and 10% in steps
of 1%. A concentration of 10% is highly unlikely, however as reported by Verhaegen
et al. it is the concentration of off–the–shelf contrast material and should serve as
an upper limit of the enhancements achievable with this technique. Furthermore,
it is to be expected that once a distribution methodology for the gold particles is
implemented we are bound to see very heterogeneous concentrations of gold in the
irradiated medium, reaching high concentrations locally.
All concentration related simulations were performed with the broad spectrum,
for reasons made clear in the results section.
2.3.3. Auger electrons As mentioned above, the contribution of the Auger electrons
could be estimated by tagging the electrons released due to Auger cascades in the
cell of interest. The number of generated Auger electrons could then be linked to the
energy of the source.
This to find the optimal energy for Auger electron generation. Below energies
of 1keV MCNPX does not track the electrons and the energy is considered to be
deposited locally. The simulations were performed for all energies as listed above.
2.4. Analysis
2.4.1. Energy Dependence The energy dependence is reviewed for the maximal
concentration of 10%, this because any differences between the energies would be
magnified, as well as reduce the statistical errors in our monte carlo calculations. We
define three types of dose enhancement:
Absolute Enhancement (Ea): The ratio of the dose deposited in the gold–
containing structure to the dose deposition in a run with exact same geometry
without gold present.
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OAR Enhancement (EOAR) : The ratio of the dose deposited in the gold–
containing structure to the dose deposited in another structure in the geometry
not containing gold, representing an Organ at Risk (OAR).
Skin ratio (ES) : The ratio of the dose deposited in the gold–containing structure
to a layer 1mm under the skin. Which is a special case of EOAR.
We determined the energy deposited per unit mass by counting the energy deposited by
electrons using the MCNPX tally F6:E. This underestimates the effectively deposited
dose slightly as it does not take into account the energy expended to generate the
photon initiated ionization. However, this ionization is likely not contributing to a
biological effect as it is mainly through interaction with the gold atom which does
not form part of the cell structure. The difference between F6:E and F6:P (Energy
transferred by photons, which includes electrons) is about 1%. However the electron
energy deposition is better defined spatially.
2.4.2. Concentration The results from the concentration study were analyzed in
function of absolute enhancement. The variation Ea was fit using a linear relationship
and a second order polynomial. The fit was performed using a minimization of a
χ2–function taking into account the simulation errors.
2.5. Radiobiological effect
To estimate the relative effect of the change in spectrum and the increase in the
contribution by Auger–electrons we used a fast monte carlo model of biological damage
as proposed by Semenenko and Stewart[18] which has been shown to obtain the same
results as track code monte carlo codes as proposed by Nikjoo et al. [19]. The approach
used here determines the amount of different damage to a DNA–molecule from direct
ionization as well as through the generation of radicals. It then produces a yield (y)
in percentage of the different types of damage ranging from single strand breaks to
complex clustered double strand breaks for interacting electrons of a given energy (E).
The methodology used to incorporate this information in our calculations is as follows.
(i) For every energy available in the energy deposition histogram we used the code
provided by Semenenko and Stewart to generate the yields of the different types
of DNA–damage making sure that the lowest energy is included. The yield is
given as percentage per cell and per Gy (%cell−1Gy−1).
(ii) The data was fit as a function of energy of the electron using an equation of the
form:
y(E) = a+ bEc (1)
with a, b, and c variable parameters. Figure 2 shows y(E) for single strand breaks
and double strand breaks together with the fitted parameters, which are provided
in table 1.
(iii) The total relative yield of damage of type D (YD) was then given by
YD =
Emax∑
E=Emin
yD(E)F (E) (2)
With F(E) the normalized histogram of deposited energy as a function of energy
of the depositing electrons (in MCNPX tally F6:E divided by the total energy).
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par SSB DSB
a 1136.3 ± 0.040 49.656 ± 0.019
b -0.1735 ± 0.0037 0.0569 ± 0.0020
c -0.9450 ± 0.0034 -0.9067± 0.0054
Table 1: Parameter fit for number of single resp. double strand breaks Gy−1 cell−1 using a function
of the form: a+ bxc. Energies are expressed in MeV, and confidence levels from the fit procedure are
given.
(iv) This repeated for all damage types and volumes with and without nano–particles.
(v) The ratio’s of the different yields for these volumes provides the relative yield.
For reasons of simplicity we chose to concentrate on the yields of single and double
strand breaks. The latter being defined as strand breaks on different DNA–helices not
more than 10 base pairs apart[19].
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Figure 2: The yield of double strand breaks as defined by Nikjoo et al. fit with a function having the
general form: a+ bxc, with a, b, and c being parameters.
3. Results
3.1. Enhancement
Figures 3a and 3b show the maximal enhancements (i.e. 10% solution) of the dose in
the volume containing GNP (target) compared to the skin and organ at risk structures.
The skin ratio shows two local maxima at 60keV and at 90 keV. The OAR, which
is positioned downstream of the target structure decreases monotonically reflecting a
shielding effect due to the increased photon absorption in the target.
Figure 4 shows the absolute number of Auger or Coster–Kro¨nig electrons (AE)
generated in the target. This quantity depends on the atomic structure ( local
maximum at 90keV) and the depth of the target in the medium (local maximum at
40keV). The highest number generated occurs at 90 keV. However, the energy of the
AE in the latter case is much higher than those generated with lower energy. This can
be seen in Figure 5 where the energy deposition of the various electrons is presented.
Also note that in both cases the contribution of AE to the energy deposition process
remains an order of magnitude lower. The largest part of the dose is deposited by
photo–electric (PE) and knock–on electrons.
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(a) Skin ratio
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(b) OAR Enhancement
Figure 3: Enhancement ratio’s as function of energy. For all points error bars are drawn but are too
small for visualization, as all simulations were performed to yield errors smaller than 1%
We plotted the absolute number of AE generated at the position of the GNP filled
volume. Very low energy X–rays are not able to reach this position. For this reason
we see no expression of the photoactivation threshold for the M–shell AE.
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Figure 4: The number of electrons generated from the different possible channels in the medium containing
the gold concentration as a function of energy for quasi mono–energetic beams. The point at 110keV
represents the result from a bremsstrahlung–spectrum. The Auger electrons show a maximum around 40keV
while an sudden increase is also noted at the Kα–edge. Note that there still is a substantial contribution
of Auger electrons in the bremsstrahlung (110kVp) beam.
Figure 5 provides a visualization of the energy deposition by the different types
of electrons at two different energies. It is the energy of each electron that deposits
energy in the medium. For this reason we see a continuous contribution from the
Auger electrons as they gradually lose their energy. In the 60keV beam only the L–
shell electrons are generated at the 90 keV beam the K-shell Auger electrons augment
the dose. Auger electrons can be generated in different ways. The general mechanism
is an atomic relaxation after ionization either from a photon interaction or from a
direct electron interaction. Both are plotted separately in the plots. A very small
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Figure 5: Energy spectra of energy depositing electrons in the activated volume, when using and energy
below (left) the Kα–edge of golds, contrasted with the spectrum resulting from irradiation with an photon
beam of 90keV which is above this edge (right).
contribution is noted from Auger electrons from oxygen. Both graphs extend slightly
above their nominal energy as the spectra used where quasi–mono–chromatic and thus
have a finite spectral width.
3.2. Concentration
Figure 6 shows the Absolute enhancement ratio as a function of the concentration of
gold in the cell. Ea was fit with a second order polynomial, where the quadratic factor
is small with respect to the other factors. Showing that the dose enhancement is quasi–
linear in the sense that the quadratic term in the polynomial has a small contribution.
When the second order polynomial is denoted as f(x) = ax2 + bx + c. Then the
coefficients are: a= (−0.0195± 0.0005), b = (1.386± 0.004), and c= (1.003± 0.003).
Fixing the c–coefficient to 1 gives comparable results. If a linear fit is performed the
slope is given by (1.26±0.02), a number which can be used to easily predict the impact
of concentration changes.
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Figure 6: Graph depicting the variation of the absolute enhancement factor (Ea) as a function of the
gold concentration. A second order polynomial is fit to the values using a χ2–minimization.
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3.3. Biological effect
Figure 7 shows the yield per cell and per Gy of single strand breaks (SSB) and double
strand breaks (DSB) as a function of energy. This for the three volumes under
consideration. The target volume containing GNP reflects the atomic structure in
the calculated yields. One can easily identify the when auger electrons are generated
as a function of beam energy. The addition generates increases in DSB and lowers
the contributions of SSB. However, the added tail of high energy electrons mainly
affects the DNA through SSB’s. It is only for very low energies (10 – 20keV) that the
addition of GNP changes the ratio of SSB to DSB to give the dose deposition a more
high LET character. For deeper lying structures there is no data available for 10 keV
as the photons do not penetrate deep enough to generate a meaningful contribution.
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Figure 7: Plots for generation of single strand breaks (left) and double strand breaks (right) as a function
of energy for a given dose. The curves are complementary as the number of SSB’s goes down the DSB’s
go up. In the target volume the atomic structure and resonant levels generating auger electrons are visible
but have a limited impact on the overall result with respect to the deposition being of a high or low LET
nature.
The spectrum in the target does contain more low energy electrons compared to
the OAR’s. This advantage is negated by the additional tail of high energy electrons
as illustrated in Fig. 8 where a cumulative representation of the dose deposition in
double strand breaks is shown for a beam energy of 60kev.
4. Discussion
From the data available here, one can conclude that there exists a necessity to perform
full monte carlo simulation based for these type of treatments. Not only does the
enhancement change with energy it is also imperative to monitor the concentration of
the nano–particles during treatment. Before treatments can be started methodologies
need to be developed to monitor concentrations adequately. The monitoring of the
concentration and the error of this specific measurement has a direct impact on the
dosimetry as we find a relationship of concentration to dose which is close to unity.
This implies that the uncertainty of the dosimetric planning is at least equal to the
uncertainty of this measurement.
The choice of energy of the radiation beam for treatment does not seem to be a
critical issue, as long as radiation reaches the intended volume. So, it might not be
necessary to build expensive high output mono–energetic photon sources. However,
to determine the concentration it might be necessary to do so albeit with a lower
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Figure 8: Cumulative graph of the contribution to dose from double strand breaks. For each energy bin
the contribution is added to the higher energies. For the GNP volume the contribution of low energy auger
electrons has a relatively high effect. As the higher energy electrons are added the effect diminishes.
photon flux [20, 21]. A possible alternative for measurement is the use of the same
markers with nano–particles attached, but where the gold is replaced by a radioactive
isotope[22]. Using methodology developed in nuclear medicine imaging techniques the
concentration and its variation can then be monitored over time. This approach gives
up some of the advantages as the radioactive particles will deliver a dose in the manner
we are trying to avoid. The dose, however, is only for imaging purposes and is more
limited than when a therapeutic procedure is attempted. A further approach could
be to measure concentration changes using other nano–particles attached to same
targeting agent and use non–ionizing techniques for visualization[23]. A drawback
of this technique is that due to the use of different nano–particles, the uptake and
concentration dynamics could be slightly different from the therapeutically enhanced
targeting molecules.
The impact of Auger electrons seems to be limited as they only consist of a
small fraction of the dose depositing electrons. Only at very low energies do they
seem to have an effect in increasing the efficiency of the dose deposition. Using such
low energies limits the use to superficial tumors or warrants the use of intra–operative
techniques or brachytherapy techniques using low energy sources like 125I or electronic
brachytherapy sources[24].
The data presented here does not stand alone and can be compared to
experimental data provided by other authors who have also looked at the possible
optimal energies to use for nanoparticle enhanced treatment using in–vitro techniques
as well as implementations through animal testing. Rahman and colleagues[25] used
clinical superficial X–ray machines to irradiate cells containing GNP’s at different
concentrations. Nominal energies of 80 and 150kVp showed dose enhancement. In
agreement with our calculations they show a dependence of cell survival on energy,
whereby the 80 kVp beam is shown to be more effective. It is not clear however
what the exact spectrum is that was used. In theory it could be possible to predict
the overall dose enhancement of a poly–chromatic beam from the weighted sum of
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mono–chromatic beams. Important to note is also that Rahman and colleagues found
increased cytotoxicity depending on the concentration, a factor not taken into account
in our analysis.
Brun et al. performed a comparable study also using different superficial energies
characterized by the effective energy of the X–ray beam (14.8,24.4, 29.8, 42.4, 49, and
70.1 keV). The highest enhancement was noted at 49keV, which could be considered
as a 50 keV beam. This again agrees with our calculations.
In the papers discussed above the dose is determined in water and the
enhancement factors are determined by estimating increase in cell kill. In our approach
we attempt to resolve the difference between physical dose and biological effect. Indeed
figure 7 has the physical dose removed and shows that most of the enhancement
proposed here is a consequence of increased photon absorption rather than an effect
of short ranged auger electrons.
Finally, an interesting approach is presented by Biston et al., where cis–
Platinum is introduced in rats with a glioma tumor[26]. The tumor is subsequently
irradiated with quasi–mono–energetic X–ray beams just below and above the K–edge
of platinum(Z=78). This group reports and increase of DSB damage at the higher
energy. This is in agreement with figure 7 where we see an substantial increase just
above the K–edge. However, the group has not tested their hypothesis at other
energies. From the same figure we see that there are other energies that provide
a better DSB/SSB ratio. From figure 5 we see that in all cases, and also at the
“photo–activation” energy, the contribution of auger electrons to the dose is an order
of magnitude lower than contribution from other sources. Therefore, it might not be
necessary to have mono–chromatic sources and that sources with a sufficiently high
flux could be adequate. Proposals of converting conventional linear accelerators using
low–Z targets come to mind as proposed by Robar et al, [27].
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